News
A Glimpse Into The Expert Outlook On Pacira BioSciences Through 6 Analysts
9 Apr 24
Analyst Ratings
Needham Reiterates Buy on Pacira BioSciences, Maintains $45 Price Target
9 Apr 24
News, Price Target, Reiteration, Analyst Ratings
JP Morgan Assumes Pacira BioSciences at Overweight, Announces Price Target of $45
7 Mar 24
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $57 Price Target
4 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Navigating 4 Analyst Ratings For Pacira BioSciences
1 Mar 24
Analyst Ratings
RBC Capital Maintains Outperform on Pacira BioSciences, Lowers Price Target to $45
1 Mar 24
News, Price Target, Analyst Ratings
Needham Reiterates Buy on Pacira BioSciences, Maintains $45 Price Target
1 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Pacira BioSciences Q4 Adjusted EPS $0.89 Beats $0.88 Estimate, Sales $181.24M Miss $181.66M Estimate
29 Feb 24
Earnings, News
Earnings Scheduled For February 29, 2024
29 Feb 24
Earnings
Preview: Pacira BioSciences's Earnings
28 Feb 24
Earnings
Pacira Publishes Study Of EXPAREL As Sciatic Nerve Block in Popliteal Fossa For Patients After Bunionectomy
15 Feb 24
Biotech, News, General
10 Health Care Stocks Whale Activity In Today's Session
12 Feb 24
Options
Wedbush Reiterates Outperform on Pacira BioSciences, Maintains $57 Price Target
8 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.; Agreement Allows Premier Members, At Their Discretion, To Take Advantage Of Special Pricing And Terms Pre-negotiated By Premier For EXPAREL
7 Feb 24
News, Contracts
Press releases
Thinking about buying stock in Healthequity, Pacira Biosciences, Interpublic Group of Companies, SIGA Technologies, or Sensus Healthcare?
21 Mar 24
Opinion, Press Releases
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)
20 Mar 24
News, Press Releases
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
13 Mar 24
Health Care, Press Releases, General
Pacira to Report 2023 Financial Results on Thursday February 29, 2024
22 Feb 24
News, Press Releases
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy
15 Feb 24
Health Care, Analyst Ratings, Press Releases